PSA Changes as a Surrogate for OS in Men with mCRPC

PSA Changes as a Surrogate for OS in Men with mCRPC

Andrew Armstrong, MD summarizes a Journal of Clinical Oncology article, PSA Changes as Surrogate for Overall Survival in Men with mCRPC Treated with Second-line Chemotherapy, from November 2013.

Andrew J. Armstrong, MD
Duke University School of Medicine

Click HERE to read the abstract

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe